New Combo Therapy TG-1101 + TGR-1202 - CLL Support
New Combo Therapy TG-1101 + TGR-1202
You need to be a member of this community to see this post.
Read more about...
4 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Drug Trial update - Gazyva with TGR-1202
Hi CLL friends,
I started my infusions Tuesday at OHSU in Oregon, no treatment prior. The first day
Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL
000 patients from three German CLL Study Group clinical trials has identified that unfit patients...
Clinical Utility of Chromosomal Microarray in Richter's Transformation
at 24 patients with a diagnosis of Richter transformation to DLBCL with a prior history of CLL/SLL....
EHA 2022: Outcomes Following Treatment With a Covalent BTK and BCL2 Inhibitor
nt-btk-and-bcl2-inhibitor-among-patients-with-chronic-lymphocytic-leukemia-cll-small-lymphocytic-lym
Richter Transformation Survival in CLL Appears Better Among Treatment-Naive
among patients with CLL and RT was 3.1 years. Those patients who were previously treated for CLL...
FDA Frontline Approval of Venetoclax and Obinituzumab in the USA
Question about Sll/CLL
Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD
Ibrutinib Slow but steady foreward movement.
New Dana Farber Research 
